Chargement en cours...
A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody
PURPOSE: To review pharmacokinetic and pharmacodynamic characteristics of antibodies that bind to soluble ligands within the framework of calcitonin gene-related peptide antibodies. OVERVIEW: Calcitonin gene-related peptide has been implicated in the pathophysiology of migraine. Galcanezumab is an a...
Enregistré dans:
| Publié dans: | Cephalalgia |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6710614/ https://ncbi.nlm.nih.gov/pubmed/30917684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102419840780 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|